40 Results for "

CRF1 Antagonist

" in MedChemExpress (MCE) Product Catalog:
Products (40)

40 Results for "CRF1 Antagonist" in MCE Product Catalog:

7
7 Publications Verification
Cat. No.: HY-14127
CAS No.: 195055-03-9
Purity:  99.66%
Synonyms: NBI30775
Target:  

CRFR

Research Areas:  

Neurological Disease Endocrinology

R121919 (NBI30775) is a potent and selective CRF1R antagonist with a Ki of 2 to 5 nM. R121919 has antidepressant and anxiolytic effects. R121919 alleviates defensive withdrawal in rats .
loading...
    loading...
Cat. No.: HY-106203
CAS No.: 752253-39-7
Synonyms: SSR-125543
Target:  

CFTR

Research Areas:  

Metabolic Disease

Crinecerfont (SSR-125543) is an orally effective corticotropin-releasing factor receptor type-1 (CRF1 receptor) antagonist. Crinecerfont blocks CRF1 receptor signaling to reduce adrenocorticotropic hormone secretion. Crinecerfont improves hypothalamic-pituitary-adrenal axis negative feedback sensitivity in chronically stressed mice. Crinecerfont can be used for the research of chronic stress conditions and classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency . Crinecerfont is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-12129
CAS No.: 257639-98-8
Purity:  99.7%
Target:  

CFTR

Research Areas:  

Neurological Disease

CP 154526 hydrochloride is a potent, brain-penetrant and selective corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki of 2.7 nM. CP 154526 hydrochloride shows selective for CRF1 over CRF2 (Ki = >10 μM). CP 154526 hydrochloride has anxiolytic activities .
loading...
    loading...
Cat. No.: HY-12127
CAS No.: 459856-18-9
Purity:  99.97%
Synonyms: BMS-562086
Target:  

CRFR

Research Areas:  

Neurological Disease Endocrinology

Pexacerfont is a selective corticotropin-releasing factor (CRF1) receptor antagonist with IC50 of 6.1±0.6 nM for human CRF1 receptor.
loading...
    loading...
Cat. No.: HY-14875
CAS No.: 885220-61-1
Purity:  99.93%
Synonyms: GSK561679
Target:  

CRFR

Research Areas:  

Neurological Disease Endocrinology

Verucerfont is a corticotropin-releasing factor receptor 1 (CRF1) antagonist with IC50s of ~6.1, >1000 and >1000?nM for CRF1, CRF2, and CRF-BP, respectively.
loading...
    loading...
Cat. No.: HY-14130
CAS No.: 175140-00-8
Purity:  99.68%
Target:  

CRFR

Research Areas:  

Neurological Disease Endocrinology

CP 376395 is a potent, selective, and brain-penetrable Corticotropin releasing factor 1 (CRF1) receptor antagonist .
loading...
    loading...
Cat. No.: HY-106203A
CAS No.: 321839-75-2
Purity:  98.06%
Synonyms: SSR-125543 hydrochloride
Target:  

CFTR

Research Areas:  

Metabolic Disease

Crinecerfont (SSR-125543) hydrochloride is an orally effective corticotropin-releasing factor receptor type-1 (CRF1 receptor) antagonist. Crinecerfont hydrochloride blocks CRF1 receptor signaling to reduce adrenocorticotropic hormone secretion. Crinecerfont hydrochloride improves hypothalamic-pituitary-adrenal axis negative feedback sensitivity in chronically stressed mice. Crinecerfont hydrochloride can be used for the research of chronic stress conditions and classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency . Crinecerfont hydrochloride is a click chemistry reagent, it contains an Alkyne group and can undergo copper-catalyzed azide-alkyne cycloaddition (CuAAc) with molecules containing Azide groups.
loading...
    loading...
Cat. No.: HY-P1294
CAS No.: 90880-23-2
Target:  

CRFR

Research Areas:  

Neurological Disease

α-Helical CRF(9-41) is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) is also a partial agonist of CRF1 receptor with an EC50 of 140 nM .
loading...
    loading...
Cat. No.: HY-113603
CAS No.: 1014983-00-6
Purity:  98.25%
Synonyms: SPR001; LY2371712
Target:  

CRFR

Research Areas:  

Metabolic Disease

Tildacerfont (SPR001; LY2371712) is an orally active, blood-brain barrier-penetrant selective corticotropin-releasing factor type 1 (CRF1) receptor antagonist. Tildacerfont selectively blocks CRF1 receptors, thereby inhibiting the release of pituitary adrenocorticotropic hormone (ACTH). Tildacerfont can be used in research related to congenital adrenal hyperplasia .
loading...
    loading...
Cat. No.: HY-156522
CAS No.: 2635364-30-4
Target:  

CFTR

Research Areas:  

Endocrinology

CRF1 receptor antagonist-1 (Compound 2) is a CRF1 receptor antagonist. CRF1 receptor antagonist-1 can be used for research of congenital adrenal hyperplasia (CAH) .
loading...
    loading...
Cat. No.: HY-14367
CAS No.: 786701-13-1
Purity:  98.03%
Synonyms: GW876008
Target:  

CRFR

Research Areas:  

Neurological Disease Endocrinology

Emicerfont is a corticotropin-releasing factor type 1 (CRF1) receptor antagonist with an IC50 of 66 nM.
loading...
    loading...
Cat. No.: HY-P1294A
Target:  

CRFR

Research Areas:  

Neurological Disease

α-Helical CRF(9-41) TFA is a competitive CRF2 receptor antagonist with KB of ~100 nM. α-Helical CRF(9-41) TFA is also a partial agonist of CRF1 receptor with an EC50 of 140 nM .
loading...
    loading...
Cat. No.: HY-12130
CAS No.: 157286-86-7
Target:  

CRFR

Research Areas:  

Neurological Disease

CP 154526 is a potent, brain-penetrant and selective corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki of 2.7 nM. CP 154526 shows selective for CRF1 over CRF2 (Ki = >10 μM). CP 154526 has anxiolytic activities .
loading...
    loading...
Cat. No.: HY-113603S
CAS No.: 2762751-36-8
Synonyms: SPR001-d8; LY2371712-d8
Tildacerfont-d8 (SPR001-d8; LY2371712-d8) is a deuterium labeled Tildacerfont (HY-113603). Tildacerfont (SPR001; LY2371712) is an orally active, blood-brain barrier-penetrant selective corticotropin-releasing factor type 1 (CRF1) receptor antagonist. Tildacerfont selectively blocks CRF1 receptors, thereby inhibiting the release of pituitary adrenocorticotropic hormone (ACTH). Tildacerfont can be used in research related to congenital adrenal hyperplasia .
loading...
    loading...
Cat. No.: HY-182645
CAS No.: 441060-02-2
Target:  

CRFR

Research Areas:  

Neurological Disease

CRF1 receptor antagonist-2 is an orally active, blood-brain barrier permeable CRF1 receptor antagonist, with an IC50 of 4 nM in CHO-K1 cell membranes and an IC50 of 7 nM in rat brain cell membranes. CRF1 receptor antagonist-2 exerts anxiolytic effects in swim stress-loaded rats. CRF1 receptor antagonist-2 can be used in studies related to stress-induced anxiety .
loading...
    loading...
Cat. No.: HY-103378
CAS No.: 603151-83-3
Target:  

CRFR

Research Areas:  

Neurological Disease

NBI 35965 methanesulfonate is a selective, orally active and brain-penetrant corticotropin-releasing factor receptor 1 (CRF1) antagonist with a Ki value of 4 nM and a pKi value of 8.5. NBI 35965 methanesulfonate does not inhibit CRF2. NBI 35965 methanesulfonate reduces CRF or stress-induced adrenocorticotropic hormone (ACTH) production in vivo with pIC50 values of 7.1 and 6.9, respectively. NBI 35965 methanesulfonate shows anxiolytic effects .
loading...
    loading...
Cat. No.: HY-14128
CAS No.: 268545-87-5
Synonyms: SB-723620
Target:  

CRFR

Research Areas:  

Neurological Disease

NBI-34041 (SB-723620) is a selective and orally active nonpeptide CRF1 receptor antagonist with an IC50 of 58.9 nM and a Ki of 4.0 nM for human CRF1 receptor. NBI-34041 has no inhibitory effect on the CRF2 receptor. NBI-34041 can be used for depression and anxiety disorders research.
loading...
    loading...
Cat. No.: HY-14129
CAS No.: 175139-41-0
Target:  

CRFR

Research Areas:  

Neurological Disease Endocrinology

CP 316311 is a potent and selective CRF1 receptor antagonist with an IC50 value of 6.8 nM.
loading...
    loading...
Cat. No.: HY-103379
CAS No.: 1013933-37-3
Target:  

CRFR

Research Areas:  

Neurological Disease Endocrinology

CP 376395 hydrochloride is a potent, selective, and brain-penetrable Corticotropin releasing factor 1 (CRF1) receptor antagonist .
loading...
    loading...
Cat. No.: HY-103376
CAS No.: 1215766-76-9
Target:  

CRFR

Research Areas:  

Neurological Disease

NBI-27914 (hydrochloride) is a selective Corticotropin-Releasing Factor 1 (CRF1) receptor antagonist with a Ki value of 1.7 nM .
loading...
    loading...